THE EFFECT OF INCREASED ALTITUDE ON RECOMBINANT ERYTHROPOIETIN (EPO) DOSING AND ACHIEVED HEMATOCRIT LEVELS IN END-STAGE RENAL DISEASE

被引：0
|
作者：
Brookhart, M. Alan [1 ]
Bradbury, B. D. [1 ]
Winkelmayer, W. [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02120 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2009年 / 169卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [41] Potential cost savings of erythropoietin administration in end-stage renal disease
    Hynes, DM
    Stroupe, KT
    Greer, JW
    Reda, DJ
    Frankenfield, DL
    Kaufman, JS
    Henderson, WG
    Owen, WF
    Rocco, MV
    Wish, JB
    Kang, J
    Feussner, JR
    AMERICAN JOURNAL OF MEDICINE, 2002, 112 (03): : 169 - 175
  • [42] The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease
    Ifudu, O
    Feldman, J
    Friedman, EA
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (07): : 420 - 425
  • [43] ERYTHROPOIETIN HEMATOCRIT FEEDBACK-CIRCUIT IN THE ANEMIA OF END STAGE RENAL-DISEASE
    WALLE, AJ
    WONG, GY
    CLEMONS, GK
    GARCIA, JF
    NIEDERMAYER, W
    KIDNEY INTERNATIONAL, 1987, 31 (05) : 1205 - 1209
  • [44] Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis
    Teigen, Mette Maja B.
    Duffull, Stephen
    Dang, Lily
    Johnson, David W.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (11): : 1259 - 1267
  • [45] NONCARDIAC BENEFITS OF HUMAN RECOMBINANT ERYTHROPOIETIN IN END-STAGE RENAL-FAILURE AND ANEMIA
    MORRIS, KP
    SHARP, J
    WATSON, S
    COULTHARD, MG
    ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 69 (05) : 580 - 586
  • [46] RECOMBINANT HUMAN ERYTHROPOIETIN IN PATIENTS WITH ANEMIA DUE TO END-STAGE RENAL-DISEASE - US MULTICENTER TRIALS
    SOBOTA, JT
    ERYTHROPOIETIN : FROM MOLECULAR STRUCTURE TO CLINICAL APPLICATION, 1989, 76 : 166 - 178
  • [47] Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease
    Arabul, Mahnnut
    Gullulu, Mustafa
    Yilmaz, Yusuf
    Akdag, Ibrahim
    Kahvecioglu, Serdar
    Eren, Mehmet Ali
    Dilek, Kamil
    CLINICAL BIOCHEMISTRY, 2008, 41 (13) : 1055 - 1058
  • [48] EXERCISE TOLERANCE AFTER ANEMIA CORRECTION WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN END-STAGE RENAL-DISEASE
    BARALDI, E
    MONTINI, G
    ZANCONATO, S
    ZACCHELLO, G
    ZACCHELLO, F
    PEDIATRIC NEPHROLOGY, 1990, 4 (06) : 623 - 626
  • [49] IMMUNOLOGICAL EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON END-STAGE RENAL-DISEASE PEDIATRIC AND ADULT PATIENTS
    SALVATI, F
    LIANI, M
    LATORRE, M
    GOLATO, M
    DISCIASCIO, N
    PIETRZYK, J
    DYRAS, P
    NEPHRON, 1994, 68 (04): : 510 - 511
  • [50] CLINICAL-TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) FOR ANEMIA OF END-STAGE RENAL-DISEASE
    PARK, SJ
    KIM, MS
    PARK, MI
    YANG, SH
    PARK, SE
    LEE, SR
    KIDNEY INTERNATIONAL, 1992, 41 (05) : 1457 - 1458
12345